XNYS
HLF
Market cap1.34bUSD
Jul 09, Last price
12.90USD
1D
2.63%
1Q
-15.30%
Jan 2017
-46.41%
IPO
251.02%
Name
Herbalife Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||